Ameritas Investment Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ameritas Investment Partners’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,803	Closed	-$6.57K	–	3220
2024 Q1	$6.57K	Hold	9,803	–	–	﹤0.01%	2909
2023 Q4	$5.33K	Hold	9,803	–	–	﹤0.01%	2962
2023 Q3	$5.88K	Hold	9,803	–	–	﹤0.01%	2963
2023 Q2	$12.7K	Hold	9,803	–	–	﹤0.01%	2813
2023 Q1	$17.3K	Hold	9,803	–	–	﹤0.01%	2523
2022 Q4	$33.7K	Hold	9,803	–	–	﹤0.01%	2296
2022 Q3	$48K	Hold	9,803	–	–	﹤0.01%	2009
2022 Q2	$40K	Hold	9,803	–	–	﹤0.01%	2138
2022 Q1	$57K	Hold	9,803	–	–	﹤0.01%	1992
2021 Q4	$74K	Hold	9,803	–	–	﹤0.01%	1874
2021 Q3	$88K	Hold	9,803	–	–	﹤0.01%	1770
2021 Q2	$117K	Hold	9,803	–	–	﹤0.01%	1628
2021 Q1	$123K	Hold	9,803	–	–	﹤0.01%	1539
2020 Q4	$153K	Hold	9,803	–	–	0.01%	1299
2020 Q3	$93K	Hold	9,803	–	–	﹤0.01%	1473
2020 Q2	$88K	Hold	9,803	–	–	﹤0.01%	1490
2020 Q1	$62K	Hold	9,803	–	–	﹤0.01%	1541
2019 Q4	$82K	Hold	9,803	–	–	﹤0.01%	1628
2019 Q3	$89K	Hold	9,803	–	–	﹤0.01%	1543
2019 Q2	$106K	Buy	9,803 +1,538	+19%	+$16.4K	﹤0.01%	1467
2019 Q1	$79K	Hold	8,265	–	–	﹤0.01%	1624
2018 Q4	$95K	Hold	8,265	–	–	0.01%	1419
2018 Q3	$140K	Hold	8,265	–	–	0.01%	1325
2018 Q2	$117K	Buy	8,265 +1,198	+17%	+$19.9K	0.01%	1437
2018 Q1	$134K	Hold	7,067	–	–	0.01%	1305
2017 Q4	$116K	Buy	7,067 +1,311	+23%	+$19.5K	0.01%	1422
2017 Q3	$76K	Hold	5,756	–	–	﹤0.01%	1623
2017 Q2	$51K	Hold	5,756	–	–	﹤0.01%	1889
2017 Q1	$30K	Buy	+5,756	New	+$23.1K	﹤0.01%	2166

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Partners's SGMO Position: Q2 2024 in Review

Ameritas Investment Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 9,803 shares — an estimated $6.57K sold.

Ameritas Investment Partners first reported a position in SGMO in Q1 2017 and held it in 29 quarters. The position peaked at $153K in Q4 2020. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

Ameritas Investment Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
Ameritas Investment Partners sold 9,803 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $6.57K.
Ameritas Investment Partners first reported a position in SANGAMO THERAPEUTICS INC in Q1 2017 and held it in 29 quarters.
Ameritas Investment Partners's SANGAMO THERAPEUTICS INC position peaked at $153K in Q4 2020.
129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.